<?xml version="1.0" encoding="UTF-8"?><xml><records><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Arman Yurisaldi Saleh</style></author><author><style face="normal" font="default" size="100%">Dwi Arwandi Yogi Saputra</style></author><author><style face="normal" font="default" size="100%">Riezky Valentina</style></author><author><style face="normal" font="default" size="100%">Tirta Darmawan Susanto</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">How Extensively is Herbal Medicine Used as a Therapy for Insomnia? A Bibliometric Study</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Antiepileptic</style></keyword><keyword><style  face="normal" font="default" size="100%">Bibliometric</style></keyword><keyword><style  face="normal" font="default" size="100%">Carbamazepine</style></keyword><keyword><style  face="normal" font="default" size="100%">Neuroprotective</style></keyword><keyword><style  face="normal" font="default" size="100%">Riluzole</style></keyword><keyword><style  face="normal" font="default" size="100%">Topiramat</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2025</style></year><pub-dates><date><style  face="normal" font="default" size="100%">June 2025</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">17</style></volume><pages><style face="normal" font="default" size="100%">342-364</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Introduction: &lt;/strong&gt;This bibliometric study explores the use of herbal medicine as a treatment for insomnia, identifying trends and gaps in existing literature. It provides a comprehensive overview of the current state of research, guiding future efforts and improving care quality for insomnia patients. &lt;strong&gt;Materials and methods: &lt;/strong&gt;This research aims to explore the evolution of scientific disciplines by finding and identifying trends, patterns and correlations in scientific texts related to certain topics. The focus of this study was on insomnia, therapy, and &quot;herbal medicine&quot; using both quantitative and qualitative analysis. &lt;strong&gt;Results and discussion:&lt;/strong&gt; The study evaluates the use of herbal medicine for insomnia, finding a significant increase in publications but a lack of information on correct dosage. This highlights a gap in literature and calls for further research on dosage and methodological standards to improve its effectiveness.; and &lt;strong&gt;Conclusions:&lt;/strong&gt; The study confirms the effectiveness of herbal medicine as an insomnia therapy, but highlights the need for further research on appropriate dosage for safer and more effective treatment. This research was conducted in January 2025.&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">3</style></issue><work-type><style face="normal" font="default" size="100%">Research Article</style></work-type><section><style face="normal" font="default" size="100%">342</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Arman Yurisaldi Saleh&lt;sup&gt;1*&lt;/sup&gt;, Dwi Arwandi Yogi Saputra&lt;sup&gt;2&lt;/sup&gt;, Riezky Valentina&lt;sup&gt;3&lt;/sup&gt;, Tirta Darmawan Susanto&lt;sup&gt;4&lt;/sup&gt; &lt;/strong&gt;&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;1&lt;/sup&gt;Neurology Department Faculty of Medicine UPN Veteran Jakarta, INDONESIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;2&lt;/sup&gt;Department of Public Health Sciences, Faculty of Medicine, UPN Veteran Jakarta, INDONESIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;3&lt;/sup&gt;Neurology Department Faculty of Medicine UPN Veteran Jakarta, INDONESIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;4&lt;/sup&gt;Family Medicine and Primary Care Department, Universitas Pelita Harapan, INDONESIA.&lt;/p&gt;
</style></auth-address></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Arman Yurisaldi Saleh</style></author><author><style face="normal" font="default" size="100%">Dwi Arwandi Yogi Saputra</style></author><author><style face="normal" font="default" size="100%">Riezky Valentina</style></author><author><style face="normal" font="default" size="100%">Tirta Darmawan Susanto</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">The Miracle Moringa Oleifera Tree: A Bibliometric Review of Its Neuroprotective Properties</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Brain</style></keyword><keyword><style  face="normal" font="default" size="100%">Herb</style></keyword><keyword><style  face="normal" font="default" size="100%">Moringa oleifera</style></keyword><keyword><style  face="normal" font="default" size="100%">Natural Agent</style></keyword><keyword><style  face="normal" font="default" size="100%">Neuroprotective</style></keyword><keyword><style  face="normal" font="default" size="100%">Therapy</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2025</style></year><pub-dates><date><style  face="normal" font="default" size="100%">April 2025</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">17</style></volume><pages><style face="normal" font="default" size="100%">258-276</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Introduction:&lt;/strong&gt; With its anti-inflammatory and antioxidant capabilities, Moringa oleifera is gaining interest for its neuroprotective potential. This bibliometric analysis examines Moringa oleifera research trends, gaps, and future prospects, focusing on its function in cognitive deficits and neurodegenerative disorders like Alzheimer's. Topiramate and riluzole's neuroprotective effects are also discussed.; &lt;strong&gt;Materials and methods:&lt;/strong&gt; Research trends in Moringa oleifera were examined using Scopus-indexed literature. The plant parts studied (leaves, seeds, roots), doses, and methods were key. The review included antiepileptic medication trials to complement their neuroprotective properties.&lt;strong&gt; Results and discussion: &lt;/strong&gt;Antioxidant and phytochemical properties made Moringa oleifera a promising neuroprotectant, according to the review. However, dose reporting and plant part specification variations compromised findings' reliability and reproducibility. To maintain methodological consistency, dose-response studies, uniform reporting techniques, and interdisciplinary collaboration are future research topics. Antiepileptic medications like topiramate and riluzole modulate neurotransmitter systems and provide neuroprotection with natural products. &lt;strong&gt;Conclusions: &lt;/strong&gt;This analysis emphasizes the necessity for rigorous research and standardized methods to enhance Moringa oleifera and related pharmacological compounds' therapeutic potential. Addressing these obstacles will improve findings' reliability and clinical application, enabling evidencebased neurological condition treatments. This research was conducted in January 2025.&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">2</style></issue><work-type><style face="normal" font="default" size="100%">Review Article</style></work-type><section><style face="normal" font="default" size="100%">258</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Arman Yurisaldi Saleh&lt;sup&gt;1*&lt;/sup&gt;, Dwi Arwandi Yogi Saputra&lt;sup&gt;2&lt;/sup&gt;, Riezky Valentina&lt;sup&gt;3&lt;/sup&gt;, Tirta Darmawan Susanto&lt;sup&gt;4&lt;/sup&gt; &lt;/strong&gt;&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;1&lt;/sup&gt;Neurology Department Faculty of Medicine UPN Veteran Jakarta, INDONESIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;2&lt;/sup&gt;Department of Public Health Sciences, Faculty of Medicine, UPN Veteran Jakarta, INDONESIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;3&lt;/sup&gt;Neurology Department Faculty of Medicine UPN Veteran Jakarta, INDONESIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;4&lt;/sup&gt;Family Medicine and Primary Care Department, Universitas Pelita Harapan, INDONESIA.&lt;/p&gt;
</style></auth-address></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Muhammad Arifin Parenrengi</style></author><author><style face="normal" font="default" size="100%">Ahmad Data Dariansyah</style></author><author><style face="normal" font="default" size="100%">Wihasto Suryaningtyas</style></author><author><style face="normal" font="default" size="100%">Dyah Fauziah</style></author><author><style face="normal" font="default" size="100%">I Ketut Sudiana</style></author><author><style face="normal" font="default" size="100%">Budi Utomo</style></author><author><style face="normal" font="default" size="100%">Prastiya Indra Gunawan</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Effects of Cerebrospinal Fluid Drainage on Pro-Inflammatory and Anti-Inflammatory Cytokines Expression in the Subventricular Zone of Kaolin-Induced Hydrocephalic Rats</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">cerebrospinal fluid drainage</style></keyword><keyword><style  face="normal" font="default" size="100%">Cytokines</style></keyword><keyword><style  face="normal" font="default" size="100%">Kaolin-induced hydrocephalus</style></keyword><keyword><style  face="normal" font="default" size="100%">Neuroinflammation</style></keyword><keyword><style  face="normal" font="default" size="100%">Neuroprotective</style></keyword><keyword><style  face="normal" font="default" size="100%">subventricular zone</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2024</style></year><pub-dates><date><style  face="normal" font="default" size="100%">February 2024</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">16</style></volume><pages><style face="normal" font="default" size="100%">20-27</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Background:&lt;/strong&gt; To determine the neuroprotective effect of CSF drainage by analyzing its impact on the expression and the ratio of pro- and anti-inflammatory cytokines in the subventricular zone in kaolininduced hydrocephalic rats. &lt;strong&gt;Method:&lt;/strong&gt; Sprague-Dawley rats of 23 weeks of age (n=36) were used in this study. The rats were randomly divided into normal control, hydrocephalus, and CSF drainage-treated groups. Hydrocephalus was obtained by injecting 0,05 cc of 20% kaolin suspension into the cisterna magna. The CSF drainage-treated group had ventricular tapping seven days after kaolin induction. The rats were sacrificed 7, 14, or 21 days after kaolin induction. The brain was removed and prepared for immunohistochemistry analysis to detect IL-1&lt;em&gt;β&lt;/em&gt;, IL-6, TNF-&lt;em&gt;α&lt;/em&gt;, and IL-10 cytokines expression. &lt;strong&gt;Results: &lt;/strong&gt;Immunohistochemistry analysis revealed that the expression of pro-inflammatory cytokines was significantly increased in hydrocephalus groups than in the control group. In contrast, the expression of anti-inflammatory cytokine was significantly decreased. CSF drainage had a neuroprotective effect by reducing pro-inflammatory cytokine expression and increasing anti-inflammatory cytokine expression. In the hydrocephalus group, the ratios of IL-1&lt;em&gt;β&lt;/em&gt;/IL-10, IL-6/IL-10, and TNF-&lt;em&gt;α&lt;/em&gt;/IL-10 increased toward a pro-inflammatory status. After CSF drainage, the ratios of IL-1&lt;em&gt;β&lt;/em&gt;/IL-10, IL-6/IL-10, and TNF-&lt;em&gt;α&lt;/em&gt;/IL-10 shifted toward an anti-inflammatory status. &lt;strong&gt;Conclusion: &lt;/strong&gt;CSF drainage protects the brain from excessive neuroinflammatory processes in kaolin-induced hydrocephalic rats. Additional investigation is warranted to ascertain the use of inflammatory cytokines expression as a valuable biomarker for hydrocephalus. Furthermore, research on anti-inflammatory drug administration in clinical settings is required.&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">1</style></issue><work-type><style face="normal" font="default" size="100%">Original Article</style></work-type><section><style face="normal" font="default" size="100%">20</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p&gt;&lt;strong&gt;Muhammad Arifin Parenrengi&lt;sup&gt;1,*&lt;/sup&gt;, Ahmad Data Dariansyah&lt;sup&gt;1&lt;/sup&gt;, Wihasto Suryaningtyas&lt;sup&gt;1&lt;/sup&gt;, Dyah Fauziah&lt;sup&gt;2&lt;/sup&gt;, I Ketut Sudiana&lt;sup&gt;2&lt;/sup&gt;, Budi Utomo&lt;sup&gt;3&lt;/sup&gt;, Prastiya Indra Gunawan&lt;sup&gt;4&lt;/sup&gt;&lt;/strong&gt;&lt;/p&gt;

&lt;p&gt;&lt;sup&gt;1&lt;/sup&gt;Department of Neurosurgery, Faculty of Medicine, Universitas Airlangga - Dr. Soetomo General Academic Hospital, Surabaya, INDONESIA.&lt;/p&gt;

&lt;p&gt;&lt;sup&gt;2&lt;/sup&gt;Department of Anatomical Pathology, Faculty of Medicine, Universitas Airlangga, Surabaya, INDONESIA.&lt;/p&gt;

&lt;p&gt;&lt;sup&gt;3&lt;/sup&gt;Department of Public Health and Preventive Medicine, Faculty of Medicine, Universitas Airlangga, Surabaya, INDONESIA.&lt;/p&gt;

&lt;p&gt;&lt;sup&gt;4&lt;/sup&gt;Department of Child Health, Faculty of Medicine, Universitas Airlangga, Surabaya, INDONESIA.&lt;/p&gt;
</style></auth-address></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Amelia Shinta Prasetya</style></author><author><style face="normal" font="default" size="100%">Evelyn Komaratih</style></author><author><style face="normal" font="default" size="100%">Wimbo Sasono</style></author><author><style face="normal" font="default" size="100%">Mercia Chrysanti</style></author><author><style face="normal" font="default" size="100%">Maria Debora Niken Larasati</style></author><author><style face="normal" font="default" size="100%">I Ketut Sudiana</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Intravitreal Resveratrol as Anti Apoptotic Agent Against Retinal  Ganglion Cell Loss in Ischemic Reperfusion Injury</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Apoptosis</style></keyword><keyword><style  face="normal" font="default" size="100%">Glaucoma</style></keyword><keyword><style  face="normal" font="default" size="100%">Ischemic-reperfusion injury</style></keyword><keyword><style  face="normal" font="default" size="100%">Neuroprotective</style></keyword><keyword><style  face="normal" font="default" size="100%">Resveratrol</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2023</style></year><pub-dates><date><style  face="normal" font="default" size="100%">December 2023</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">15</style></volume><pages><style face="normal" font="default" size="100%">1207-1212</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Background:&lt;/strong&gt; Glaucoma is an optic neuropathy caused by the apoptosis of retinal ganglion cells and results in progressive retinal ganglion cell injury. A decrease in intraocular pressure (IOP) is a modifiable risk factor for slowing the progression of the disease, and can be accomplished through medication, laser therapy, or surgery. Even though the intraocular pressure has decreased and attained normal levels, the injury to the retinal ganglion cells continues in some cases. It is believed that neuroprotective administration has a positive effect on preventing the loss of retinal ganglion cells.&lt;strong&gt; Methods:&lt;/strong&gt; Bax and Caspase-3 expression were measured involving 20 eyeballs of Rattus Norvegicus by immunohistochemistry examination. I-R injury was developed by increasing intraocular pressure (IOP) through the intracameral balanced salt solution (BSS) injection, then lowered after 60 minutes. Samples were divided into 4 groups: control, no further injection group, phosphate-buffered saline (PBS)-injected group and resveratrol-injected group. Each group was enucleated at days 7, 0, 7, and 7, respectively. Data with a non-normal distribution were examined using the Kruskal-Wallis test, and if the outcome was significant, the Mann-Whitney test. &lt;strong&gt;Results:&lt;/strong&gt; The highest mean Bax and Caspase-3 expression was found in PBS injected and enucleated at day 7 group (G2), 0.96±0.40 and 0.72 ± 0.30, respectively. When compared to PBS injection, the expression of Bax and Caspase-3 was lower in the resveratrol-injected group. &lt;strong&gt;Conclusion: &lt;/strong&gt;Bax and Caspase-3 expressions were lower in the intravitreal injection of Resveratrol in the dose of 100 µM following the I-R injury group compared to the group without intravitreal Resveratrol injection.&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">6</style></issue><work-type><style face="normal" font="default" size="100%">Research Article</style></work-type><section><style face="normal" font="default" size="100%">1207</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p&gt;&lt;strong&gt;Amelia Shinta Prasetya&lt;sup&gt;1&lt;/sup&gt; , Evelyn Komaratih&lt;sup&gt;1,*&lt;/sup&gt;, Wimbo Sasono&lt;sup&gt;1&lt;/sup&gt; , Mercia Chrysanti&lt;sup&gt;1&lt;/sup&gt; , Maria Debora Niken Larasati&lt;sup&gt;1&lt;/sup&gt; , I Ketut Sudiana&lt;sup&gt;2&lt;/sup&gt;&lt;/strong&gt;&lt;/p&gt;

&lt;p&gt;&lt;sup&gt;1&lt;/sup&gt;Department of Ophthalmology, Faculty of Medicine, Universitas Airlangga/Dr. Soetomo General Hospital, Surabaya, INDONESIA.&lt;/p&gt;

&lt;p&gt;&lt;sup&gt;2&lt;/sup&gt;Departement of Anatomical Pathology, Faculty of Medicine, Universitas Airlangga, Surabaya, INDONESIA.&lt;/p&gt;
</style></auth-address></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Veronica Nunez-Urquiza</style></author><author><style face="normal" font="default" size="100%">Juana Villeda-Hernandez</style></author><author><style face="normal" font="default" size="100%">Elizur Montiel-Arcos</style></author><author><style face="normal" font="default" size="100%">Isaac Tello</style></author><author><style face="normal" font="default" size="100%">Victoria Campos-Pena</style></author><author><style face="normal" font="default" size="100%">Maribel Herrera-Ruiz</style></author><author><style face="normal" font="default" size="100%">María del Carmen Gutiérrez</style></author><author><style face="normal" font="default" size="100%">Vera Petricevich</style></author><author><style face="normal" font="default" size="100%">María Angélica Santana</style></author><author><style face="normal" font="default" size="100%">Martha Navarro</style></author><author><style face="normal" font="default" size="100%">Angélica Berenice Aguilar-Guadarrama</style></author><author><style face="normal" font="default" size="100%">Gabriel Navarrete-Vázquez</style></author><author><style face="normal" font="default" size="100%">Irene Perea-Arango</style></author><author><style face="normal" font="default" size="100%">Ismael Leon-Rivera</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Evaluation of the Anticonvulsant, Anxiolytic, Sedative, and Neuroprotective Activities of Polysaccharides from Mycelium of Two Ganoderma Species</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">a- and b-glucan</style></keyword><keyword><style  face="normal" font="default" size="100%">Anticonvulsant</style></keyword><keyword><style  face="normal" font="default" size="100%">GABA</style></keyword><keyword><style  face="normal" font="default" size="100%">Ganoderma curtissi</style></keyword><keyword><style  face="normal" font="default" size="100%">Ganoderma sp</style></keyword><keyword><style  face="normal" font="default" size="100%">Neuroprotective</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2021</style></year><pub-dates><date><style  face="normal" font="default" size="100%">September 2021</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">13</style></volume><pages><style face="normal" font="default" size="100%">1161-1173</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Background: &lt;/strong&gt;&lt;em&gt;Ganoderma lucidum&lt;/em&gt; has been used as a medicinal mushroom since centuries in East Asia. Recent reports have shown that metabolites isolated from &lt;em&gt;Ganoderma&lt;/em&gt; species have shown effects on central nervous system. &lt;strong&gt;Objective:&amp;nbsp;&lt;/strong&gt;To determine the neuroprotective, anticonvulsant, anxiolytic, and sedative effects of &lt;em&gt;Ganoderma &lt;/em&gt;sp. and &lt;em&gt;Ganoderma curtisii&lt;/em&gt; polysaccharides. &lt;strong&gt;Methods:&lt;/strong&gt; Polysaccharides (Gsp-PS2 or Gc-PS2) were isolated from two &lt;em&gt;Ganoderma mycelia&lt;/em&gt; submerged cultures. Acute toxicity effects of Gc-PS2 or Gsp-PS2 on mice were treated orally with doses of 50 - 2000 mg/kg. Anticonvulsant activity was determined using three chemoconvulsants: kainic acid (KA), strychnine, or pentylenetetrazole (PTZ). Anxiolytic-like effects were determined using the elevated plus maze test on mice. GABA release evoked by GC-PS2 or Gsp-PS2 content was determined by HPLC. Neuroprotective effects of Gsp-PS2 or Gc-PS2 were determined by glial activation, histopathological changes, and immunohistochemistry. &lt;strong&gt;Results:&lt;/strong&gt; Gc-PS2 or Gsp-PS2 showed neuroprotective activity by diminishing neuronal death, reducing glial activation and Neu-N expression levels. Gsp-PS2 or Gc-PS2 inhibited convulsions in the KA model. An anxiolytic-like, but not a sedative effect was reported in mice treated with Gc-PS2 or Gsp-PS2. Polysaccharides Gc-PS2 or Gsp-PS2 evoked endogenous GABA release and increased its concentration within the incubation medium. Pretreatment with Gsp-PS2 or Gc-PS2 showed a reduction of the LPSinduced NO production. Gc-PS2 or Gsp-PS2 did not produce toxic effects. &lt;strong&gt;Conclusion:&amp;nbsp;&lt;/strong&gt;&lt;em&gt;Ganoderma &lt;/em&gt;sp. or &lt;em&gt;Ganoderma curtisii &lt;/em&gt;polysaccharides showed neuroprotective and anticonvulsant activities in animal models. The anticonvulsant activity may involve the GABAergic neurotransmision.&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">5</style></issue><work-type><style face="normal" font="default" size="100%">Research Article</style></work-type><section><style face="normal" font="default" size="100%">1161</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Verónica Núñez-Urquiza,&lt;sup&gt;1&lt;/sup&gt; Juana Villeda- Hernández,&lt;sup&gt;2&lt;/sup&gt; Elizur Montiel-Arcos,&lt;sup&gt;3&lt;/sup&gt; Isaac Tello,&lt;sup&gt;3&lt;/sup&gt; Victoria Campos-Peña,&lt;sup&gt;2&lt;/sup&gt; Maribel Herrera-Ruiz,&lt;sup&gt;4&lt;/sup&gt; María del Carmen Gutiérrez,&lt;sup&gt;5&lt;/sup&gt; Vera Petricevich,&lt;sup&gt;6&lt;/sup&gt; María Angélica Santana,&lt;sup&gt;7&lt;/sup&gt; Martha Navarro,&lt;sup&gt;2&lt;/sup&gt; Angélica Berenice Aguilar-Guadarrama,&lt;sup&gt;1&lt;/sup&gt; Gabriel Navarrete-Vázquez,&lt;sup&gt;8&lt;/sup&gt; Irene Perea- Arango,&lt;sup&gt;5&lt;/sup&gt; Ismael León-Rivera&lt;sup&gt;1,&lt;/sup&gt;*&lt;/strong&gt;&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;1&lt;/sup&gt;Centro de Investigaciones Químicas, IICBA, Universidad Autónoma del Estado de Morelos, Avenida Universidad 1001, Col. Chamilpa 62209 Cuernavaca, Morelos, Estados Unidos Mexicanos, MEXICO.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;2&lt;/sup&gt;Instituto Nacional de Neurología y Neurocirugía Manuel Velasco Suárez. Avenida Insurgentes Sur No. 3877 Col. La Fama Tlalpan, Ciudad de México, Estados Unidos Mexicanos.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;3&lt;/sup&gt;Centro de Investigaciones Biológicas, Universidad Autónoma del Estado de Morelos, Avenida Universidad 1001, Col. Chamilpa 62209 Cuernavaca, Morelos, Estados Unidos Mexicanos.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;4&lt;/sup&gt;Centro de Investigación Biomédica del Sur, Instituto Mexicano del Seguro Social, Argentina 1, Col. Centro, Xochitepec, Morelos, Estados Unidos Mexicanos.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;5&lt;/sup&gt;Centro de Investigación en Biotecnología, IICBA, Universidad Autónoma del Estado de Morelos, Avenida Universidad 1001, Col. Chamilpa 62209 Cuernavaca, Morelos, Estados Unidos Mexicanos.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;6&lt;/sup&gt;Facultad de Medicina, Universidad Autónoma del Estado de Morelos, Avenida Universidad 1001, Col. Chamilpa 62209 Cuernavaca, Morelos, Estados Unidos Mexicanos.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;7&lt;/sup&gt;Centro de Investigación en Dinámica Celular, IICBA, Universidad Autónoma del Estado de Morelos, Avenida Universidad 1001, Col. Chamilpa 62209 Cuernavaca, Morelos, Estados Unidos Mexicanos.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;8&lt;/sup&gt;Facultad de Farmacia, Universidad Autónoma del Estado de Morelos, Avenida Universidad 1001, Col. Chamilpa 62209 Cuernavaca, Morelos, Estados Unidos Mexicanos.&lt;/p&gt;
</style></auth-address></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Ismael Leon-Rivera</style></author><author><style face="normal" font="default" size="100%">Juana Villeda-Hernandez</style></author><author><style face="normal" font="default" size="100%">Elizur Montiel-Arcos</style></author><author><style face="normal" font="default" size="100%">Isaac Tello</style></author><author><style face="normal" font="default" size="100%">Maria Yolanda Rios</style></author><author><style face="normal" font="default" size="100%">Samuel Estrada-Soto</style></author><author><style face="normal" font="default" size="100%">Angelica Berenice Aguilar</style></author><author><style face="normal" font="default" size="100%">Veronica Nunez-Urquiza</style></author><author><style face="normal" font="default" size="100%">Jazmin Mendez-Miron</style></author><author><style face="normal" font="default" size="100%">Victoria Campos-Pena</style></author><author><style face="normal" font="default" size="100%">Sergio Hidalgo-Figueroa</style></author><author><style face="normal" font="default" size="100%">Eva Hernandez</style></author><author><style face="normal" font="default" size="100%">Gerardo Hurtado</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Neuroprotective Effects of Ganoderma curtisii Polysaccharides After Kainic Acid-Seizure Induced</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Anti-inflammatory</style></keyword><keyword><style  face="normal" font="default" size="100%">Anticonvulsant</style></keyword><keyword><style  face="normal" font="default" size="100%">Ganoderma curtisii</style></keyword><keyword><style  face="normal" font="default" size="100%">Neuroprotective</style></keyword><keyword><style  face="normal" font="default" size="100%">β-glucan</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2019</style></year><pub-dates><date><style  face="normal" font="default" size="100%">September 2019</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">11</style></volume><pages><style face="normal" font="default" size="100%">1046-1054</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Background:&lt;/strong&gt; Epilepsy is one of the major neurological disorders affecting world population. Although, some &lt;em&gt;Ganoderma&lt;/em&gt; species have shown neuroprotective activities, the effects of polysaccharides isolated from &lt;em&gt;Ganoderma curtisii&lt;/em&gt; on epileptic seizures have not been reported. &lt;strong&gt;Objective:&lt;/strong&gt; The aims of the present study were to determine whether treatment with a polysaccharide fraction (GCPS-2) from a Mexican &lt;em&gt;Ganoderma curtisii &lt;/em&gt;strain can reduce seizures, and the increases in the levels of apoptotic molecules and inflammatory cytokines in kainic acid-induced seizure mouse model. &lt;strong&gt;Materials and Methods:&lt;/strong&gt; Rats were separated in groups: Control group received 2.5% Tween 20 solution; GCPS-2 groups were administered GCPS-2 (10, 40, or 80 mg/kg); KA group received KA 10 mg/kg; GCPS-2+KA received GCPS- 2 and 30 min later KA. Pathological changes in neuronal morphology, expression of B-cell lymphoma-2, and pro-inflammatory cytokines (interleukin1-β and tumor necrosis factor-α) in the rat hippocampus and cortex were determined by immunohistochemistry.&lt;strong&gt; Results: &lt;/strong&gt;&lt;em&gt;Ganoderma curtisii&lt;/em&gt; soluble polysaccharides (GCPS-2) inhibited convulsions in rats. Moreover, treatment with GCPS-2 reduced the increased levels of apoptotic signaling molecules (Bcl-2) and proinflammatory mediators (in the kainic acid-treated hippocampus and cortex). &lt;strong&gt;Conclusion:&lt;/strong&gt; &lt;em&gt;Ganoderma curtisii&lt;/em&gt; soluble polysaccharides have a neuroprotective potential against epilepsy, partially through its ability to inhibit neurotoxic events in the &lt;em&gt;in vivo&lt;/em&gt; hippocampus and cortex.&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">5</style></issue><work-type><style face="normal" font="default" size="100%">Original Article</style></work-type><section><style face="normal" font="default" size="100%">1046</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Ismael León-Rivera&lt;sup&gt;1&lt;/sup&gt;*, Juana Villeda-Hernández&lt;sup&gt;2&lt;/sup&gt;, Elizur Montiel-Arcos&lt;sup&gt;3&lt;/sup&gt;, Isaac Tello&lt;sup&gt;3&lt;/sup&gt;, María Yolanda Rios&lt;sup&gt;1&lt;/sup&gt;, Samuel Estrada-Soto&lt;sup&gt;4&lt;/sup&gt;, Angélica Berenice Aguilar&lt;sup&gt;1&lt;/sup&gt;, Verónica Núñez-Urquiza&lt;sup&gt;1&lt;/sup&gt;, Jazmín Méndez-Mirón&lt;sup&gt;5&lt;/sup&gt;, Victoria Campos-Peña&lt;sup&gt;2&lt;/sup&gt;, Sergio Hidalgo-Figueroa&lt;sup&gt;6&lt;/sup&gt;, Eva Hernández&lt;sup&gt;7&lt;/sup&gt;, Gerardo Hurtado&lt;sup&gt;7&lt;/sup&gt; &lt;/strong&gt;&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;1&lt;/sup&gt;Centro de Investigaciones Químicas, IICBA, Universidad Autónoma del Estado de Morelos, Avenida Universidad 1001, Col. Chamilpa 62209 Cuernavaca, Morelos, ESTADOS UNIDOS MEXICANOS.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;2&lt;/sup&gt;Instituto Nacional de Neurología y Neurocirugía Manuel Velasco Suárez. Avenida Insurgentes Sur No. 3877 Col. La Fama Tlalpan, Ciudad de México, ESTADOS UNIDOS MEXICANOS.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;3&lt;/sup&gt;Centro de Investigaciones Biológicas, Universidad Autónoma del Estado de Morelos, Avenida Universidad 1001, Col. Chamilpa 62209 Cuernavaca, Morelos, ESTADOS UNIDOS MEXICANOS.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;4&lt;/sup&gt;Facultad de Farmacia, Universidad Autónoma del Estado de Morelos, Avenida Universidad 1001, Col. Chamilpa 62209 Cuernavaca, Morelos, ESTADOS UNIDOS MEXICANOS.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;5&lt;/sup&gt;Facultad de Ciencias Biológicas, Universidad Autónoma del Estado de Morelos, Avenida Universidad 1001, Col. Chamilpa 62209 Cuernavaca, Morelos, ESTADOS UNIDOS MEXICANOS.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;6&lt;/sup&gt;CONACYT-IPICYT Consorcio de Investigación, Innovación y Desarrollo para las Zonas Áridas, 78216 San Luis Potosí, ESTADOS UNIDOS MEXICANOS.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;7&lt;/sup&gt;Instituto Nacional de Salud Pública. Avenida Universidad 565, Col. Santa María Ahuacatitla Cuernavaca, Morelos, ESTADOS UNIDOS MEXICANOS.&lt;/p&gt;
</style></auth-address></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Rezi Riadhi Syahdi</style></author><author><style face="normal" font="default" size="100%">Chindy Dwi Martinah</style></author><author><style face="normal" font="default" size="100%">Arry Yanuar</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Virtual Screening of Indonesian Herbal Database as alpha-Amino-3- Hydroxy-5-Methyl-4 Isoxazolepropionic Acid (AMPA) Antagonist</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">AMPA receptor</style></keyword><keyword><style  face="normal" font="default" size="100%">AutoDock</style></keyword><keyword><style  face="normal" font="default" size="100%">Herbal plants</style></keyword><keyword><style  face="normal" font="default" size="100%">Neuroprotective</style></keyword><keyword><style  face="normal" font="default" size="100%">Virtual Screening</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2019</style></year><pub-dates><date><style  face="normal" font="default" size="100%">October 2019</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">11</style></volume><pages><style face="normal" font="default" size="100%">1204-1210</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Objective:&lt;/strong&gt; Ischemic stroke is one type of circulatory disturbance caused by blood clots that block blood flow to the brain. One of the impact of ischemia is nerve cell damage due to excitotoxicity. Inhibition of the ionotropic glutamate receptor such as the AMPA receptor, becomes an essential approach to the treatment of ischemia. This study aims to explore the possibility of an Indonesian herbal compound as an AMPA receptor antagonist. &lt;strong&gt;Methods:&lt;/strong&gt; In this study, virtual screening of 2233 herbal compounds was performed by docking method using AutoDock to find the antagonist candidate of AMPA receptor from Indonesian herbal database. The virtual screening method was validated by an area under curve (AUC) of the ROC curve and enrichment factor (EF). Lipinski’s Rule of Five was used to filter the screening result. &lt;strong&gt;Results:&lt;/strong&gt; The validation of virtual screening result showed that AUC was 0.9385 and EF 1% was 23.5550. The screening result of Indonesian herbal database showed top five compound sanggenol O, blazeispirol X, progesterone, nimolicinol and boeravinone F (-8.51; -8.39; -8.19; -8.17; -8.08 kcal/mol, respectively) and have interaction with TYR61 and THR91 residues of AMPA receptor. &lt;strong&gt;Conclusion:&lt;/strong&gt; Five compounds of the Indonesia herbal database were shown as hits of AMPA receptor antagonist based on the docking method.&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">6</style></issue><work-type><style face="normal" font="default" size="100%">Original Article</style></work-type><section><style face="normal" font="default" size="100%">1204</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Rezi Riadhi Syahdi, Chindy Dwi Martinah, Arry Yanuar* &lt;/strong&gt;&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;Biomedical Computation and Drug Design Laboratory, Faculty of Pharmacy, Universitas Indonesia, Depok, INDONESIA.&lt;/p&gt;
</style></auth-address></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Aslam Pathan</style></author><author><style face="normal" font="default" size="100%">Abdulrahman Alshahrani</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Neuroprotective Effects of Valeriana wallichii on Scopolamine Induced Learning and Memory Impairment in Rats</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Alzheimer’s disease</style></keyword><keyword><style  face="normal" font="default" size="100%">Elevated Plus Maze</style></keyword><keyword><style  face="normal" font="default" size="100%">Neuroprotective</style></keyword><keyword><style  face="normal" font="default" size="100%">Scopolamine</style></keyword><keyword><style  face="normal" font="default" size="100%">Valeriana wallichii</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2018</style></year><pub-dates><date><style  face="normal" font="default" size="100%">November 2018</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">10</style></volume><pages><style face="normal" font="default" size="100%">s38-s41</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;strong&gt;Objective:&lt;/strong&gt; Alzheimer&amp;rsquo;s disease (AD) is the most common cause of dementia in worldwide, treatment options is extremely limited and costly. The present study was conducted to investigate and validate the traditional claim of &lt;em&gt;Valeriana wallichii&lt;/em&gt; on scopolamine treated rats as an AD model. &lt;strong&gt;Methods:&lt;/strong&gt; The &lt;em&gt;Valeriana wallichii&lt;/em&gt; rhizome ethanol extract (25 mg/kg/day) was administered daily along with scopolamine for a period of 14 days following which the elevated plus maze test were performed to assess learning and memory. Rats treated with scopolamine or vehicle only were also included in the experiment. &lt;strong&gt;Result:&lt;/strong&gt; The study demonstrate that scopolamine treatment resulted in learning and memory deficits which were partially and significantly ameliorated by the &lt;em&gt;Valeriana wallichii&lt;/em&gt; rhizome ethanol extract.&lt;strong&gt; Conclusion:&lt;/strong&gt; The study demonstrates the ability of the&lt;em&gt; Valeriana wallichii&lt;/em&gt; rhizome ethanol extract to reverse scopolamine-induced learning and memory deficits in rats.&lt;/p&gt;</style></abstract><issue><style face="normal" font="default" size="100%">6s</style></issue><work-type><style face="normal" font="default" size="100%">Original Article</style></work-type><section><style face="normal" font="default" size="100%">s38</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;strong&gt;Aslam Pathan&lt;sup&gt;1,*&lt;/sup&gt;, Abdulrahman Alshahrani&lt;sup&gt;2 &lt;/sup&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;sup&gt;1&lt;/sup&gt;Department of Pharmacology and Therapeutics College of Medicine, Shaqra University, Ministry of Higher Education, Shaqra-11961, KINGDOM OF SAUDI ARABIA.&lt;/p&gt;
&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;sup&gt;2&lt;/sup&gt;Department of Internal Medicine (Neurology), College of Medicine, Shaqra University, Ministry of Higher Education, Shaqra-11961, KINGDOM OF SAUDI ARABIA.&lt;/p&gt;</style></auth-address></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Swaminathan Gomathi</style></author><author><style face="normal" font="default" size="100%">Rajagopal Shanmuga Sundaram</style></author><author><style face="normal" font="default" size="100%">Vellaichamy Muthupandi Annapandian</style></author><author><style face="normal" font="default" size="100%">Manickam Vijayabaskaran</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Neuroprotective Effect of Pedalium murex Linn. Leaf against Lipopolysaccharide Induced Behavioural Disorders in Rats</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Behavioural studies</style></keyword><keyword><style  face="normal" font="default" size="100%">Learning</style></keyword><keyword><style  face="normal" font="default" size="100%">Memory</style></keyword><keyword><style  face="normal" font="default" size="100%">Neuroprotective</style></keyword><keyword><style  face="normal" font="default" size="100%">Oxidative stress</style></keyword><keyword><style  face="normal" font="default" size="100%">Pedalium murex.</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2017</style></year><pub-dates><date><style  face="normal" font="default" size="100%">September 2017</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">9</style></volume><pages><style face="normal" font="default" size="100%">957-962</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;strong&gt;Introduction:&lt;/strong&gt; Effective treatment is necessary to minimize the neuronal damage and oxidative stress. Traditional medicines offer potent pharmacological activity with minimal side effects compared to synthetic drugs to treat such chronic disorders. There is no renowned remedy for arrest or rescuing infection or inflammation-induced brain damage. The present study was aimed to evaluate the neuroprotective effect of ethanol extract of &lt;em&gt;Pedalium murex&lt;/em&gt; Linn. (EEPM) leaves against lipopolysaccharide (LPS)-induced endotoxemia. &lt;strong&gt;Methods:&lt;/strong&gt; Neurodegeneration was induced in rats with a single intraperitoneal injection of LPS (1 mg/kg). The induced endotoxemia constantly linked with battery of behavioural tests viz., choice reaction time task (CRT), 8-arm radial maze (RAM) and water maze test (WMT). At the end of the study, rats were sacrificed, brain hippocampal region was removed and biochemical parameters were measured. &lt;strong&gt;Results:&lt;/strong&gt; In WMT swimming length (cm) was increased in LPS-treated rats when compared to control animals, the swimming length (EEPM; 400 mg/kg) was found to be significant; in RAM, different doses of EEPM at 100, 200 and 400 mg/kg decreased the number of errors in entry 4.00&amp;plusmn;0.36, 4.16&amp;plusmn;0.16and 3.33&amp;plusmn;2.79 respectively when compared with control animals (2.66&amp;plusmn; 0.21). EEPM at 400 mg/kg showed significant activity, in CRT apparatus increased incorrect lever pressing was observed in LPS-treated rats when compared to control animals. Incorrect lever pressing was minimized by EEPM at 400 mg/kg (43.5&amp;plusmn;2.40). &lt;strong&gt;Conclusions:&lt;/strong&gt; Our results showed that EEPM is a hopeful aspirant for hindrance of infection and inflammation induced brain damage by LPS.&lt;/p&gt;</style></abstract><issue><style face="normal" font="default" size="100%">6</style></issue><work-type><style face="normal" font="default" size="100%">Original Article</style></work-type><section><style face="normal" font="default" size="100%">957</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;strong&gt;Swaminathan Gomathi&lt;sup&gt;1&lt;/sup&gt;, Rajagopal Shanmuga Sundaram&lt;sup&gt;2*&lt;/sup&gt;, Vellaichamy Muthupandi Annapandian&lt;sup&gt;2&lt;/sup&gt;, Manickam Vijayabaskaran&lt;sup&gt;1&lt;/sup&gt; &lt;/strong&gt;&lt;/p&gt;
&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;sup&gt;1&lt;/sup&gt;Department of Pharmaceutical Chemistry and JKK Nattraja College of Pharmacy, Komarapalayam, Namakkal, Tamil Nadu &amp;ndash; 638183, INDIA.&lt;/p&gt;
&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;sup&gt;2&lt;/sup&gt;Department of Pharmacology, Chemistry and JKK Nattraja College of Pharmacy, Komarapalayam, Namakkal, Tamil Nadu &amp;ndash; 638183, INDIA.&lt;/p&gt;</style></auth-address></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">PS Dhivya</style></author><author><style face="normal" font="default" size="100%">P Selvamani</style></author><author><style face="normal" font="default" size="100%">S Latha</style></author><author><style face="normal" font="default" size="100%">Vasudevan Mani</style></author><author><style face="normal" font="default" size="100%">Nur Syamimi Mohd Azahan</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">In vitro Evaluation of Acetylcholinesterase Inhibitory and Neuroprotective Activity in Commiphora species: A Comparative Study</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Acetylcholinesterase</style></keyword><keyword><style  face="normal" font="default" size="100%">Aβ25-35</style></keyword><keyword><style  face="normal" font="default" size="100%">Commiphiora pubescens</style></keyword><keyword><style  face="normal" font="default" size="100%">Commiphora berryi</style></keyword><keyword><style  face="normal" font="default" size="100%">Commiphora caudata</style></keyword><keyword><style  face="normal" font="default" size="100%">Neuroprotective</style></keyword><keyword><style  face="normal" font="default" size="100%">SH-SY5Y Cell line</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">202</style></year><pub-dates><date><style  face="normal" font="default" size="100%">September 2020</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">12</style></volume><pages><style face="normal" font="default" size="100%">1223-1231</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Introduction: &lt;/strong&gt;Herbal medicines are widely used in the therapeutic intervention that could delay the onset of Neurodegenerative diseases like, Alzheimer’s disease. Despite intensive advancements in the field of research currently available therapeutic strategies are often limited due to their adverse effects. Hence there is a need for the search for novel compounds for effective medications to treat neurocognitive deficits. &lt;strong&gt;Objective: &lt;/strong&gt;The present study focused on acetylcholinesterase inhibitory and neuroprotective activity of &lt;em&gt;Commiphora species&lt;/em&gt; plant for their possible use in Alzheimer’s disease. &lt;strong&gt;Methods:&lt;/strong&gt; Phytochemical screening, TLC bioautographic and colourimetric assay was performed to quantify their acetylcholinesterase inhibitory activity of ethanolic extracts of the &lt;em&gt;Commiphora species&lt;/em&gt;. The MTT assay was carried to evaluate the neuroprotective effect against the Aβ-induced cytotoxicity in SHSY5Y cell lines. &lt;strong&gt;Results: &lt;/strong&gt;The bark of &lt;em&gt;Commiphora berryi&lt;/em&gt;, leaves of &lt;em&gt;Commiphora caudata&lt;/em&gt; and &lt;em&gt;Commiphora pubescens&lt;/em&gt; were found abundant in flavonoids, glycosides, steroids and terpenoids. Further, the ethanol extract of &lt;em&gt;Commiphora berryi&lt;/em&gt; (65.48% ± 0.10) showed the highest acetylcholinesterase inhibitory activity. The Aβ&lt;sub&gt;25-35&lt;/sub&gt; induced cell damage was as evidenced at a concentration of 20μM. The neuroprotective effect of the ethanol extracts was examined in neurodegenerative cells induced by Aβ&lt;sub&gt;25-35&lt;/sub&gt;. On pretreatment with plant extracts, significant improvement in cell viability was observed as 63.42 ± 2.02% (25μg/ml) for &lt;em&gt;Commiphora berryi&lt;/em&gt;. The maximum percentage of &lt;em&gt;in-vitro&lt;/em&gt; AChE inhibition and neuroprotective effect was effective in the ethanol bark extract of &lt;em&gt;Commiphora berryi&lt;/em&gt;. &lt;strong&gt;Conclusion:&lt;/strong&gt; The results are very rousing to continue the screening of more unexplored plant species could be used for the development of novel bioactive compounds to treat the many diseases, especially for Alzheimer's disease.&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">6</style></issue><work-type><style face="normal" font="default" size="100%">Original Article</style></work-type><section><style face="normal" font="default" size="100%">1223</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;PS Dhivya&lt;sup&gt;1,&lt;/sup&gt;*, P Selvamani&lt;sup&gt;2&lt;/sup&gt;, S Latha&lt;sup&gt;3&lt;/sup&gt;, Vasudevan Mani&lt;sup&gt;4&lt;/sup&gt;, Nur Syamimi Mohd Azahan&lt;sup&gt;5 &lt;/sup&gt;&lt;/strong&gt;&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;1&lt;/sup&gt;Department of Pharmaceutical Technology, Anna University, Bharathidasan Institute of Technology Campus, Tiruchirappalli, Tamil Nadu, INDIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;2&lt;/sup&gt;Department of Pharmaceutical Technology, Centre for Excellence in Nanobio Translational Research (CENTRE), Anna University, Bharathidasan Institute of Technology Campus, Tiruchirappalli, Tamil Nadu, INDIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;3&lt;/sup&gt;Department of Pharmaceutical Technology, Centre for Excellence in Nanobio Translational Research (CENTRE), Anna University, Bharathidasan Institute of Technology Campus, Tiruchirappalli, Tamil Nadu, INDIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;4&lt;/sup&gt;Department of Pharmacology and Toxicology, College of Pharmacy, Qassim University, Buraydah, KINGDOM OF SAUDI ARABIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;5&lt;/sup&gt;Faculty of Pharmacy, UniversitiTeknologi MARA (UiTM), 42300 Bandar PuncakAlam, Selangor, MALAYSIA.&lt;/p&gt;
</style></auth-address></record></records></xml>